JP2016534048A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534048A5 JP2016534048A5 JP2016522040A JP2016522040A JP2016534048A5 JP 2016534048 A5 JP2016534048 A5 JP 2016534048A5 JP 2016522040 A JP2016522040 A JP 2016522040A JP 2016522040 A JP2016522040 A JP 2016522040A JP 2016534048 A5 JP2016534048 A5 JP 2016534048A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- compound according
- aryl
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361887988P | 2013-10-08 | 2013-10-08 | |
| US61/887,988 | 2013-10-08 | ||
| PCT/CA2014/050974 WO2015051458A1 (en) | 2013-10-08 | 2014-10-08 | Non-platimun-based anti-cancer compounds for use in targeted chemotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534048A JP2016534048A (ja) | 2016-11-04 |
| JP2016534048A5 true JP2016534048A5 (enExample) | 2018-02-15 |
| JP6765302B2 JP6765302B2 (ja) | 2020-10-07 |
Family
ID=52812401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522040A Expired - Fee Related JP6765302B2 (ja) | 2013-10-08 | 2014-10-08 | 標的化化学療法に使用するための非白金ベースの抗がん化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10463662B2 (enExample) |
| EP (2) | EP3578176A1 (enExample) |
| JP (1) | JP6765302B2 (enExample) |
| KR (1) | KR102307387B1 (enExample) |
| CN (2) | CN114380700A (enExample) |
| AU (1) | AU2014334461B2 (enExample) |
| CA (1) | CA2926571C (enExample) |
| WO (1) | WO2015051458A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10421756B2 (en) | 2015-07-06 | 2019-09-24 | Rodin Therapeutics, Inc. | Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase |
| LT3319959T (lt) | 2015-07-06 | 2021-12-27 | Alkermes, Inc. | Histono deacetilazės hetero-halogeno inhibitoriai |
| EA202092442A3 (ru) | 2016-06-07 | 2021-08-31 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| ES2846833T3 (es) | 2016-07-18 | 2021-07-29 | Janssen Pharmaceutica Nv | Ligandos de obtención de imágenes de tau por PET |
| ES2909086T3 (es) | 2017-01-11 | 2022-05-05 | Alkermes Inc | Inhibidores bicíclicos de histona desacetilasa |
| WO2018172984A1 (en) | 2017-03-23 | 2018-09-27 | Jacobio Pharmaceuticals Co., Ltd. | Novel heterocyclic derivatives useful as shp2 inhibitors |
| SG11202000970WA (en) | 2017-08-07 | 2020-02-27 | Rodin Therapeutics Inc | Bicyclic inhibitors of histone deacetylase |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3822261A (en) * | 1972-10-30 | 1974-07-02 | Dow Chemical Co | 5,6-dihalo-2-fluoroalkyl-1h-imidazo(4,5-b)pyrazines |
| JPH09510695A (ja) * | 1994-01-03 | 1997-10-28 | エイシア・ファーマシュウティカルズ，インコーポレイテッド | ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用 |
| US7622117B2 (en) * | 2002-04-17 | 2009-11-24 | Dynamis Therapeutics, Inc. | 3-deoxyglucosone and skin |
| DE102004054545A1 (de) * | 2004-09-16 | 2006-04-06 | Max-Delbrück-Centrum für Molekulare Medizin | Änderung des Beladungszustandes von MHC-Molekülen |
| US20060089316A1 (en) * | 2004-10-25 | 2006-04-27 | Brown Truman R | Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof |
| GB0428082D0 (en) * | 2004-12-22 | 2005-01-26 | Welcome Trust The Ltd | Therapeutic compounds |
| CA2598460C (en) * | 2005-02-16 | 2013-05-07 | Schering Corporation | Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| CA2672940A1 (en) * | 2006-12-20 | 2008-07-10 | Schering Corporation | Novel jnk inhibitors |
| CA2963784A1 (en) * | 2007-06-08 | 2008-12-18 | Mannkind Corporation | Ire-1.alpha. inhibitors |
| CN101778839A (zh) * | 2007-08-16 | 2010-07-14 | 霍夫曼-拉罗奇有限公司 | 取代的乙内酰脲 |
| DK200801600A (en) * | 2008-11-17 | 2010-05-18 | Engkilde Kaare | Method for treatment of inflammatory diseases |
| US8722720B2 (en) * | 2009-10-28 | 2014-05-13 | Newlink Genetics Corporation | Imidazole derivatives as IDO inhibitors |
| WO2012096813A1 (en) * | 2011-01-11 | 2012-07-19 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| JP6321673B2 (ja) * | 2012-12-20 | 2018-05-09 | ルゥ チーン−ビン | 放射線と組み合わせて使用するための放射線増感剤化合物 |
-
2014
- 2014-10-08 EP EP19188591.2A patent/EP3578176A1/en not_active Withdrawn
- 2014-10-08 AU AU2014334461A patent/AU2014334461B2/en not_active Ceased
- 2014-10-08 CA CA2926571A patent/CA2926571C/en active Active
- 2014-10-08 CN CN202111465211.9A patent/CN114380700A/zh active Pending
- 2014-10-08 CN CN201480066862.2A patent/CN106232581A/zh active Pending
- 2014-10-08 JP JP2016522040A patent/JP6765302B2/ja not_active Expired - Fee Related
- 2014-10-08 EP EP14852850.8A patent/EP3055287B1/en active Active
- 2014-10-08 WO PCT/CA2014/050974 patent/WO2015051458A1/en not_active Ceased
- 2014-10-08 KR KR1020167012036A patent/KR102307387B1/ko not_active Expired - Fee Related
- 2014-10-08 US US15/028,169 patent/US10463662B2/en active Active
-
2019
- 2019-09-18 US US16/574,800 patent/US11446294B2/en active Active